Moderna: Early coronavirus vaccine results are encouraging

Ted S. Warren, AP Photo, File

Moderna: Early coronavirus vaccine results are encouraging

By The Associated Press | Updated - May 18, 2020 at 11:03 a.m. | Posted - May 18, 2020 at 8:28 a.m.

CAMBRIDGE, Mass. (AP) — An experimental vaccine against the coronavirus showed encouraging results in very early testing, triggering hoped-for immune responses in eight healthy, middle-aged volunteers, its maker announced Monday.

The vaccine by Cambridge, Massachusetts-based Moderna Inc., generated antibodies similar to those seen in people who have recovered from COVID-19 in study volunteers who were given either a low or medium dose.

In the next phase of the study, led by the U.S. National Institutes of Health, researchers will try to determine which dose is best for a definitive experiment that they aim to start in July.

The vaccine seems safe so far, the company said. A high dose version is being dropped after spurring some short-term side effects.

Worldwide, about a dozen vaccine candidates are in the first stages of testing or nearing it.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Related Links

Related Stories

The Associated Press


    Catch up on the top news and features from, sent weekly.
    By subscribing, you acknowledge and agree to's Terms of Use and Privacy Policy.

    KSL Weather Forecast